#3
Vertex Pharmaceuticals
The $110B market cap company that functionally cured cystic fibrosis with Trikafta, helping 90% of patients with $9B in revenue. Vertex is now applying the same precision medicine approach to pain, diabetes, and kidney disease, targeting a $20B addressable market.
Photos (1)
Comments on "Vertex Pharmaceuticals"
Have a take on this ranking?
Comments are how the argument actually happens here. Posting one needs a free account — it takes about a minute.
No comments yet.
The first comment sets the terms of the argument.